Complex Regional Pain Syndrome Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Complex Regional Pain Syndrome Treatment Market is anticipated to grow with a CAGR of nearly 2% during the forecast period 2022-2028.

Complex regional pain syndrome is a debilitating chronic pain condition that causes severe pain, especially in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, changes in skin color, and demineralization of the macerated bone. CRPS is often considered to develop as a result of dysfunction of the peripheral and central nervous systems, so it is sometimes referred to as reflex sympathetic dystrophy syndrome. Complex regional pain syndrome (CRPS) is divided into two similar forms, called CRPS type 1 (reflex sympathetic dystrophy or RSD) and CRPS type 2 (causal). The former type mentioned is used for individuals with confirmed nerve damage, while the latter type is used to refer to patients without confirmed nerve damage.

Market Segments

By Disease Type:

• CRPS I
• CRPS II
• CRPS – NOS

By Drug Type:

• T-121
• NTRX-07
• Neridronic Acid
• Others

Key Players

Some of the key players are Abiogen Pharma S.p.A., AlgoRx Pharmaceuticals, Inc., Amgen Inc.,Bayer AG, Celgene Corporation, Cell Targeting Technologies, CeNeS Pharmaceuticals plc, Danish Pain Research Center, Eli Lilly & Co., Endo Pharmaceuticals, Forest Laboratories Inc., GlaxoSmithKline plc, Grünenthal GmbH Johnson & Johnson, Justus Liebig University Giessen, King Pharmaceuticals Inc., Lee\’s Pharmaceutical Holdings Limited, National Institute of Nursing Research (NINR), NeurogesX, Inc., Pfizer, Inc., Stichting Achmea Slachtofferhulp Samenleving, and University of California.

Scope of the Report

The research study analyzes the global Complex Regional Pain Syndrome Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Complex Regional Pain Syndrome Treatment Market Report

1. What was the Complex Regional Pain Syndrome Treatment Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Complex Regional Pain Syndrome Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Complex Regional Pain Syndrome Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.